BPC-157

Join Dr. Ben Synth as he investigates BPC-157, the stomach-derived peptide fueling biohacking trends despite limited human research. This series separates evidence from hype, exploring why social media drives global demand for this experimental compound and whether it truly delivers on its promises.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why promising rodent studies don't guarantee human safety.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth examines how BPC-157 evolved from obscure Croatian research into a multimillion-dollar phenomenon. We trace the compound's journey through bodybuilding forums, Joe Rogan's podcast, wellness influencers, and unregulated supply chains—exploring the gap between rodent data and human evidence, while discussing why desperate patients turn to experimental peptides despite FDA warnings and zero large-scale clinical trials.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Join AI host Ben Synth as he examines BPC-157's remarkable animal research showing accelerated healing, while confronting a stark reality: virtually no rigorous human clinical trials exist. From Zagreb rat studies to biohacking forums, we explore why this peptide's promising mechanisms haven't translated to proven human medicine and what that gap reveals about drug development.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.